Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells

Molecular Nutrition and Food Research

Volumn 56, Issue 6, 2012, Pages 923-934

  Xiong, Ailian ^a   Yu, Weiping ^b   Tiwary, Richa ^b   Sanders, Bob G ^b   Kline, Kimberly ^a  

^a Section of Molecular Genetics and Microbiology   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Apoptosis; Breast cancer; Docosahexaenoic acid; ER stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CHROMAN DERIVATIVE; CYSTEINE PROTEINASE INHIBITOR; DDIT3 PROTEIN, HUMAN; DOCOSAHEXAENOIC ACID; DRUG DERIVATIVE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INITIATOR CASPASE; MESSENGER RNA; PLASTOCHROMANOL 8; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

ALPHA-TOCOPHEROL; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; BREAST NEOPLASMS; CASPASES, INITIATOR; CELL LINE, TUMOR; CHROMANS; CYSTEINE PROTEINASE INHIBITORS; DOCOSAHEXAENOIC ACIDS; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; REACTIVE OXYGEN SPECIES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR CHOP; VITAMIN E;

EID: 84862513345     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200027     Document Type: Article

References (38)

1. Teng, Y. H., Thike, A. A., Wong, N. S., Tan, P. H., Therapeutic targets in triple negative breast cancer-where are we now? Recent Pat. Anticancer Drug Discov. 2011, 6, 196-209.
2. Foulkes, W. D., Stefansson, I. M., Chappuis, P. O., Bégin, L. R. et al., Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J. Natl. Cancer Inst. 2003, 95, 1482-1485.
3. Irshad, S., Ellis, P., Tutt, A., Molecular heterogeneity of triple-negative breast cancer and its clinical implications. Curr. Opin Oncol. 2011, 23, 566-577.
4. Kaur, G., Cameron-Smith, D., Garg, M., Sinclair, A. J., Docosapentaenoic acid (22;5n-3): a review of its biological effects. Prog. Lipid Res. 2011, 50, 28-34.
5. Calder, P.C., Fatty acids and inflammation: the cutting edge between food and pharma. Eur. J. Pharmacol. 2011, 668, S50-S58.
6. Abeywardena, M. Y., Patten, G. S., Role of ω3 longchain polyunsaturated fatty acids in reducing cardio-metabolic risk factors. Endocr. Metab. Immune Disord. Drug Targets 2011, 11, 232-246.
7. Kang, K. S., Wang, P., Yamabe, N., Fukui, M. et al., Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One 2010, 22, e10296.
8. Blanckaert, V., Ulmann, L., Mimouni, V., Antol, J. et al., Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int. J. Oncol. 2010, 36, 737-742.
9. Serini, S., Fasano, E., Piccioni, E., Monego, G. et al., DHA induces apoptosis and differentiation in human melanoma cells in vitro: involvement of HuR-mediated COX-2 mRNA stabilization and β-catenin nuclear translocation. Carcinogenesis 2012, 33, 164-173.
10. Zand, H., Rahimipour, A., Salimi, S., Shafiee, S. M., Docosahexaenoic acid sensitizes Ramos cells to gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression. Mol. Cell Biochem. 2008, 317, 113-120.
11. Cavazos, D. A., Price, R. S., Apte, S. S., deGraffenried, L. A., Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. Prostate 2011, 71, 1420-1428.
12. Jakobsen, C. H., Størvold, G. L., Bremseth, H., Follestad, T. et al., DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis. J. Lipid Res. 2008, 49, 2089-2100.
13. Kline, K., Lawson, K. A., Yu, W., Sanders, B. G., Vitamin E and cancer. Vitam. Horm. 2007, 76, 435-461.
14. Aggarwal, B. B., Sundaram, C., Prasad, S., Kannappan, R., Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem. Pharmacol. 2010, 80, 1613-1631.
15. Park, S. K., Sanders, B. G., Kline, K., Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast Cancer Res. Treat. 2010, 124, 361-375.
16. Ling, M. T., Luk, S. U., Al-Ejeh, F., Khanna, K. K., Tocotrienol as a potential anticancer agent. Carcinogenesis 2012, 33, 233-239.
17. Meganathan, P., Veerasenan, S. D., Selvaduray, K. R., Tocotrienols and breast cancer: the evidence to date. Genes Nutr. 2012, 7, 3-9.
18. Klein, E. A., Thompson, I. M. Jr, Tangen, C. M., Crowley, J. J. et al., Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 2011, 306, 1549-1556.
19. Lehmann, B. D., Bauer, J. A., Chen, X., Melinda, E. et al., Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 2011, 121, 2750-2767.
20. Li, J., Yu, W., Tiwary, R., Park, S. K. et al., α-TEA-induced death receptor dependent apoptosis involves activation of acid sphingomyelinase and elevated ceramide-enriched cell surface membranes. Cancer Cell Int. 2010, 10, 40.
21. Tiwary, R., Yu, W., Li, J., Park, S. K. et al., Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One 2010, 5, e11865.
22. Kao, J., Salari, K., Bocanegra, M., Choi, Y-L. et al., Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009, 4, e6146.
23. Sun, H., Hu, Y., Gu, Z., Owens, R. T. et al., Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. Carcinogenesis 2011, 32, 1518-1524.
24. Chapkin, R. S., Seo, J., McMurray, D. N., Lupton, J. R., Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem. Phys. Lipids. 2008, 153, 14-23.
25. Armstrong, V. T., Brzustowicz, M. R., Wassall, S. R., Jenski, L. J. et al., Rapid flip-flop in polyunsaturated docosahexaenoate) phospholipid membranes. Arch. Biochem. Biophys. 2003, 414, 74-82.
26. Patacsil, D., Tran, A. T., Cho, Y. S., Suy, S. et al., Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cells. J. Nutr. Biochem. 2012, 23, 93-100.
27. Huang, X., Zhang, Z., Jia, L., Zhao, Y. et al., Endoplasmic reticulum stress contributes to vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells. Cancer Lett. 2010, 296, 123-131.
28. Zou, W., Yue, P., Khuri, F. R., Sun, S. Y., Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation. Cancer Res. 2008, 68, 7484-7492.
29. Park, I. J., Kim, M. J., Park, O. J., Choe, W. et al., Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells. Apoptosis 2012, 17, 248-257.
30. Pae, H. O., Jeong, S. O., Jeong, G. S., Kim, K. M. et al., Curcumin induces pro-apoptotic endoplasmic reticulum stress in human leukemia HL-60 cells. Biochem. Biophys. Res. Commun. 2007, 353, 1040-1045.
31. Magyar, J. E., Gamberucci, A., Konta, L., Margittai, E. et al., Endoplasmic reticulum stress underlying the pro-apoptotic effect of epigallocatechin gallate in mouse hepatoma cells. Int. J. Biochem. Cell Biol. 2009, 41, 694-700.
32. Kouhara, J., Yoshida, T., Nakata, S., Horinaka, M. et al., Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Int. J. Oncol. 2007, 30, 679-687.
33. Yamaguchi, H., Wang, H. G., CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem. 2004, 279, 45495-45502.
34. Siddiqui, R. A., Harvey, K. A., Xu, Z., Bammerlin, E. M. et al., Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. Biofactors 2011, 37, 399-412.
35. Malhotra, J. D., Miao, H., Zhang, K., Wolfson, A. et al., Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc. Natl. Acad. Sci. USA 2008, 105, 18525-18530.
36. Kannappan, R., Ravindran, J., Prasad, S., Sung, B. et al., Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors. Mol. Cancer Ther. 2010, 9, 2196-2207.
37. Nowak, G., Bakajsova, D., Hayes, C., Hauer-Jensen, M. et al., γ-tocotrienol protects against mitochondrial dysfunction and renal cell death. J. Pharmacol. Exp. Ther. 2012, 340, 330-338.
38. Huang, W. C., Chen, C. L., Lin, Y. S., Lin, C. F., Apoptotic sphingolipid ceramide in cancer therapy. J. Lipids 2011, 565316.